SS
IONS icon

Sunbelt Securities’s Ionis Pharmaceuticals IONS Stock Holding History

Sunbelt Securities’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.1K Hold
1,014
– – ﹤0.01% 917
2025
Q4 		$80.2K Hold
1,014
– – 0.01% 882
2025
Q3 		$66.3K Hold
1,014
– – ﹤0.01% 934
2025
Q2 		$35.4K Hold
1,014
– – ﹤0.01% 1017
2025
Q1 		$30.6K Hold
1,014
– – ﹤0.01% 1016
2024
Q4 		$35.4K Hold
1,014
– – ﹤0.01% 1017
2024
Q3 		$40.6K Hold
1,014
– – ﹤0.01% 995
2024
Q2 		$48.3K Hold
1,014
– – ﹤0.01% 911
2024
Q1 		$44K Buy
+1,014
New +$48.3K ﹤0.01% 903

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sunbelt Securities's IONS Position: Q1 2026 in Review

Sunbelt Securities held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 1,014 shares worth $76.1K. The position accounts for ﹤0.01% of the portfolio, ranked #917.

Sunbelt Securities first reported a position in IONS in Q1 2024 and has held it in 9 quarters since. The position peaked at $80.2K in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Sunbelt Securities held 1,014 shares of Ionis Pharmaceuticals worth $76.1K as of Q1 2026.
  • Sunbelt Securities left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #917 holding.
  • Sunbelt Securities first reported a position in Ionis Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Sunbelt Securities's Ionis Pharmaceuticals position peaked at $80.2K in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.